
About Xishan
Precision and Innovation in Minimally Invasive Surgery
At Xishan, we blend clinical insights with advanced engineering to empower surgeons and elevate patient care.
As a leading innovator in minimally invasive surgery, Xishan has established a globally recognized R&D and manufacturing platform delivering high-standard surgical devices and consumables certified to ISO 13485 standards.
Our mission is to enhance surgical control, simplify complex procedures, and drive clinical success across the globe.
Surgical Power Devices
Engineered for neurosurgery, spine, and ENT.
Our high-speed cutting, drilling, and milling systems integrate advanced water-cooling to deliver exceptional precision while protecting delicate tissues.
Endoscopy Systems
Transforming OR visualization.
Our ultra-HD 4K rigid endoscopes and imaging platforms reveal microscopic anatomical details for confident, precise clinical diagnoses.
Energy Surgical Units
Advancing intraoperative efficiency.
Featuring cutting-edge Ultrasonic Bone Scalpels and RF/Plasma systems, our energy solutions ensure meticulous dissection and optimal hemostasis.
Patents Approved
Professional Staff
Medical Registrations
Hospitals Covered




Our Mission
Empowering Doctors, Aiding Patients.
We dedicate our precision engineering to enhancing healthcare efficiency, enabling clinicians with reliable surgical tools, alleviating intraoperative trauma, and making advanced minimally invasive surgery safe and accessible globally.
- Enable clinicians with high-precision, intuitive surgical control.
- Reduce operative trauma and accelerate patient recovery.
- Maintain strict ISO 13485 quality and global regulatory compliance.
- Provide high-standard, cost-effective MIS tools worldwide.

Our Vision
To become a globally leading supplier of comprehensive minimally invasive surgical instruments.
Guided by our "1+2+N" strategy, we aim to pioneer digital operating room solutions—integrating Surgical Power Devices, 4K UHD Endoscopy, and Energy Surgical Units to shape the future of surgical care.
- Lead continuous innovation across Powered, Endoscopy, and Energy surgical tools.
- Define technology benchmarks by driving national and industry standards.
- Expand clinical training hubs and academic partnerships worldwide.
- Bridge clinical needs with smart, green, and sustainable manufacturing.

Our Achievements
Propelled by decades of technological breakthroughs and proprietary manufacturing.
Listed on the SSE STAR Market (Stock Code: 688576), Xishan has established a solid foundation of intellectual property, national standards, and global clinical trust since 1999.
- Spearheaded the drafting of 8 National & Industry Standards for surgical devices.
- Secured over 1,000+ Approved Patents for surgical power and MIS technologies.
- Trusted in 5,000+ Hospitals across China and 40+ Countries globally.
- Certified with CE (EU MDR), FDA, and ISO 13485 quality management systems.
- Built a state-of-the-art MIS R&D & Smart Industrialization Base.
Our Journey
Key Milestones of Our Growth Since 1999
1999
Company Inception
Chongqing Xishan Science & Technology Co., Ltd. was established on December 23rd, 1999, initiating the development of the DK-2000 series, one of the earliest surgical power devices in China.
2005
Quality Management Certification
Certified by the CMD Medical Device Quality Management System, laying a solid regulatory foundation for standard production.
2008
Independent Key Component Manufacturing
Commenced the independent production and machining of key components, significantly enhancing product consistency and quality control.
2012
Leading National Industry Standards
Appointed as the leading drafting unit for the National Medical Device Industry Standard of “Electric Bone Tissue Surgical Equipment” (Standard No: YY/T 0752-2016).
2016
Standard Release & CE Mark
The national industry standard was officially released. Simultaneously, Xishan’s surgical power devices obtained the CE Mark, marking the official entry into global markets.
2019
National Model & Technology Diversification
Awarded the title of “National Intellectual Property Model Enterprise”. Concurrently, expanded R&D into Endoscopic Visualization Systems and Energy Electrosurgical Units.
2023
SSE KCB Initial Public Offering
On June 6th, 2023, Xishan successfully listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange (Stock Code: 688576), scaling up capital to fuel innovative medical technology.
2024
Industrial Base Inauguration
The Xishan Minimally Invasive Surgery (MIS) Medical Device R&D and Industrialization Base was officially inaugurated, offering advanced manufacturing lines and green, intelligent workplaces.


